HARPAGOPHYTUM REINE DES PRÉS
Food supplement declared in France, declaration No 2021-9-639, decision dated 13 September 2021
HARPAGOPHYTUM REINE DES PRÉS (SYNERVITAL) is a food supplement declared in France. Status: declared in France, may be marketed. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- SYNERVITAL
- Food business operator placing the product on the market
- IEDBS
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 2 à 6 gélules.
- Directions for use
- Avec un grand verre d'eau.
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Allergy to salicylate derivatives, Children (under 12), Taking anticoagulants, Ulcer (stomach or duodenum)
Declaration 307773, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Harpagophytum procumbens | Racine | Poudre (de plantes séchées ou broyées) | 900 mg |
| Filipendula ulmaria (L.) Maxim. | Sommités fleuries | Poudre (de plantes séchées ou broyées) | 900 mg |
Additives
E1204
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Précautions d'emploi : - Déconseillé en cas d’ulcère (estomac ou duodenum) et de calculs biliaires.- Déconseillé en cas d’allergie aux dérivés salicilés,- Déconseillé aux enfants et adolescents,- Déconseillé sous traitement anticoagulant.-Ne pas dépasser la dose journalière recommandée-Les compléments alimentaires ne se substituent pas à une alimentation variée et équilibrée.-Tenir à l’abri de la chaleur et de l’humidité-Tenir hors de portée des enfants.
Regulatory points
- Conditions légales
Filipendula ulmaria (L.) Maxim.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Harpagophytum procumbens
Read the warning, when it applies and the studies cited
DEVIL'S CLAW - HARPAGOPHYTUM
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Harpagophytum Reine des prés Yves Ponroy, declared in 2019, withdrawal announced : different composition: 3 ingredient(s) added, 1 missing
- Harpagophytum reine des prés SYLVIE CARDON, declared in 2017 : different composition: 1 ingredient(s) added, 1 missing
Brand : SYNERVITAL
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.